Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2011

View Archived Issues

Spotlight on myotonic dystrophy: Misregulated alternative BIN1 splicing linked to muscle weakness

Novel antineoplastic agents presented

Topline phase III data on HyQ in primary immunodeficiency

NVP-BEZ-235/everolimus combination displays synergistic antitumor effects in models of NSCLC

CUPID trial supports safety and efficacy of Mydicar intracoronary gene therapy for heart failure

Niclosamide inhibits protein involved in colon cancer metastasis

Rectogesic slows lymphatic transit time of snake venom

Boehringer Ingelheim patents novel chemokine CCR2 receptor antagonists

New nicotinic acetylcholine alpha7 receptor ligands presented by NeuroSearch

Novel metabotropic mGlu5 glutamate receptor modulators developed

Novartis synthesizes new orexin receptor antagonists

French universities patent new agents for herpes simplex virus infection

Evotec and UCB form drug discovery collaboration for CNS disorders

NovaBay Pharmaceuticals provides pipeline update

Sinapis Pharma completes phase I trial of methamphetamine hydrochloride

Mesoblast receives FDA clearance for phase III bone marrow regeneration trial

Novartis initiates phase II LCQ-908 trial in hepatitis C

Achillion begins phase I trial of ACH-2928 for treatment of hepatitis C

Resminostat receives FDA orphan status in hepatocellular cancer

Eisai Europe reports phase III results showing efficacy of zonisamide in newly diagnosed epilepsy

Ildong Pharmaceutical to sell pirfenidone in South Korea under license agreement with Shionogi

Genfit reports encouraging phase II data on GFT-505 in diabetes

Treatment begins in phase Ib Ampion trial in osteoarthritis of the knee

Ipsen and Institut de cancerologie Gustave Roussy sign 3-year oncology partnership

PharmaVentures to assist Avexa in out-licensing apricitabine for HIV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...